KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 129 filers reported holding KYMERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $745,405 | -39.6% | 53,627 | -0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,233,275 | +65014.8% | 53,644 | -16.1% | 0.00% | -50.0% |
| Q1 2023 | $1,894 | +24.0% | 63,927 | +4.4% | 0.00% | 0.0% |
| Q4 2022 | $1,528 | -99.9% | 61,220 | +1.6% | 0.00% | 0.0% |
| Q3 2022 | $1,311,000 | +21.3% | 60,227 | +9.7% | 0.00% | 0.0% |
| Q2 2022 | $1,081,000 | -29.4% | 54,888 | +51.6% | 0.00% | 0.0% |
| Q1 2022 | $1,532,000 | -28.4% | 36,208 | +7.4% | 0.00% | -33.3% |
| Q4 2021 | $2,141,000 | +9.6% | 33,727 | +1.4% | 0.00% | 0.0% |
| Q3 2021 | $1,953,000 | +46.1% | 33,253 | +20.7% | 0.00% | +50.0% |
| Q2 2021 | $1,337,000 | +201.1% | 27,557 | +141.4% | 0.00% | +100.0% |
| Q1 2021 | $444,000 | -31.7% | 11,416 | +8.8% | 0.00% | 0.0% |
| Q4 2020 | $650,000 | – | 10,491 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,858,262 | $81,429,842 | 12.61% |
| Aquilo Capital Management, LLC | 782,219 | $10,872,844 | 9.85% |
| BVF INC/IL | 4,739,004 | $65,872,156 | 1.78% |
| Redmile Group, LLC | 1,868,507 | $25,972,247 | 1.24% |
| Artal Group S.A. | 1,805,346 | $25,094 | 1.08% |
| Deer Management Co. LLC | 615,895 | $8,560,941 | 1.04% |
| Avoro Capital Advisors LLC | 3,855,000 | $53,584,500 | 0.84% |
| Rock Springs Capital Management LP | 1,504,351 | $20,910,479 | 0.56% |
| AtonRa Partners | 19,172 | $266,491 | 0.56% |
| Baker Brothers Advisors | 4,750,400 | $66,030,560 | 0.38% |